Centiva Capital LP Has $281,000 Position in The Pennant Group, Inc. (NASDAQ:PNTG)

Centiva Capital LP trimmed its position in The Pennant Group, Inc. (NASDAQ:PNTG) by 40.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,884 shares of the company’s stock after selling 5,249 shares during the quarter. Centiva Capital LP’s holdings in The Pennant Group were worth $281,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp grew its stake in shares of The Pennant Group by 10.3% in the second quarter. Bank of New York Mellon Corp now owns 130,195 shares of the company’s stock valued at $3,019,000 after acquiring an additional 12,141 shares in the last quarter. Bailard Inc. bought a new position in shares of The Pennant Group during the second quarter worth approximately $253,000. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of The Pennant Group by 292.5% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,738 shares of the company’s stock valued at $504,000 after buying an additional 16,200 shares in the last quarter. Principal Financial Group Inc. boosted its stake in shares of The Pennant Group by 9.9% in the second quarter. Principal Financial Group Inc. now owns 11,029 shares of the company’s stock valued at $256,000 after buying an additional 991 shares during the period. Finally, Rhumbline Advisers increased its stake in The Pennant Group by 8.9% during the 2nd quarter. Rhumbline Advisers now owns 44,239 shares of the company’s stock worth $1,026,000 after acquiring an additional 3,611 shares during the period. Institutional investors own 85.88% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on PNTG. Royal Bank of Canada increased their target price on The Pennant Group from $26.00 to $38.00 and gave the stock an “outperform” rating in a report on Wednesday, October 23rd. Truist Financial increased their price objective on shares of The Pennant Group from $34.00 to $38.00 and gave the stock a “hold” rating in a research note on Monday, October 7th. Stephens reissued an “overweight” rating and issued a $40.00 target price on shares of The Pennant Group in a report on Wednesday, October 9th. Finally, Oppenheimer upped their price target on shares of The Pennant Group from $34.00 to $37.00 and gave the stock an “outperform” rating in a report on Friday, November 8th.

The Pennant Group Price Performance

Shares of PNTG stock opened at $30.31 on Wednesday. The Pennant Group, Inc. has a twelve month low of $13.30 and a twelve month high of $37.13. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.58. The business has a fifty day simple moving average of $32.57 and a 200 day simple moving average of $29.94. The company has a market cap of $1.04 billion, a P/E ratio of 44.57, a P/E/G ratio of 3.07 and a beta of 1.95.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.